| Authors: |
Neville MDC; Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Hinxton, UK., Lawson ARJ; Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Hinxton, UK., Sanghvi R; Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Hinxton, UK., Abascal F; Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Hinxton, UK., Pham MH; Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Hinxton, UK., Cagan A; Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Hinxton, UK., Nicola PA; Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Hinxton, UK., Bayzetinova T; Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Hinxton, UK., Baez-Ortega A; Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Hinxton, UK., Roberts K; Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Hinxton, UK., Lensing SV; Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Hinxton, UK.; Sequencing Operations, Wellcome Sanger Institute, Hinxton, UK., Widaa S; Sequencing Operations, Wellcome Sanger Institute, Hinxton, UK., Alcantara RE; Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Hinxton, UK.; Quotient Therapeutics, Saffron Walden, UK., García MP; Department of Twin Research and Genetic Epidemiology, Kings College London, London, UK., Wadge S; Department of Twin Research and Genetic Epidemiology, Kings College London, London, UK., Stratton MR; Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Hinxton, UK., Campbell PJ; Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Hinxton, UK., Small K; Department of Twin Research and Genetic Epidemiology, Kings College London, London, UK., Martincorena I; Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Hinxton, UK., Hurles ME; Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Hinxton, UK., Rahbari R; Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Hinxton, UK. rr11@sanger.ac.uk. |
